ArticleTranslational oncology2024

Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study.

Jiaqi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.